US Edition
Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans - Pharmafile
Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein research. Didier Dargent, who has served as chief executive officer (CEO), will assume the role of executive chairman. Michael Bencak, an experienced biotech executive, has been appointed as the new CEO of both Cube Biotech […] The post Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans ap…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
